NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharm...

FDA Recall #D-0180-2021 — Class III — December 22, 2020

Recall #D-0180-2021 Date: December 22, 2020 Classification: Class III Status: Terminated

Product Description

NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816

Reason for Recall

Failed Moisture Limits

Recalling Firm

Strides Pharma Inc. — East Brunswick, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

960 bottles

Distribution

PA

Code Information

Lot 7242728A; June 2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated